Radiofrequency ablation for single hepatocellular carcinoma 3 cm or less as first-line treatment

AIM: To evaluate long-term outcomes of radiofrequency (RF) ablation as first-line therapy for single hepatocellular carcinoma (HCC) ≤ 3 cm and to determine survival and prognostic factors. METHODS: We included all 184 patients who underwent RF ablation as a first-line treatment for single HCC ≤ 3 cm...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:World J Gastroenterol
Päätekijät: Gao, Jun, Wang, Shao-Hong, Ding, Xue-Mei, Sun, Wen-Bing, Li, Xiao-Long, Xin, Zong-Hai, Ning, Chun-Min, Guo, Shi-Gang
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Baishideng Publishing Group Inc 2015
Aiheet:
Retrospective Study
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4419069/
https://ncbi.nlm.nih.gov/pubmed/25954102
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i17.5287
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia